MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3238/arztebl.m2021.0374

Медицинская библиотека · Deutsches Arzteblatt international · 2021

Clinical Practice Guideline: Recommendations on the In-hospital Treatment of Patients with COVID-19.

Kluge Stefan, Malin Jakob J, Fichtner Falk, Müller Oliver J, Skoetz Nicole, Karagiannidis Christian, Guideline Development Group

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The mortality of COVID-19 patients who are admitted to a hospital because of the disease remains high. The implementation of evidence-based treatments can improve the quality of care.

METHODS

The new clinical practice guideline is based on publications retrieved by a systematic search in the Medline databases via PubMed and in the Cochrane COVID-19 trial registry, followed by a structured consensus process leading to the adoption of graded recommendations.

RESULTS

Therapeutic anticoagulation can be considered in patients who do not require intensive care and have an elevated risk of thromboembolism (for example, those with D-dimer levels ≥ 2 mg/L). For patients in intensive care, therapeutic anticoagulation has no benefit. For patients with hypoxemic respiratory insufficiency, prone positioning and an early therapy attempt with CPAP/noninvasive ventilation (CPAP, continuous positive airway pressure) or high-flow oxygen therapy is recommended. Patients with IgG-seronegativity and, at most, low-flow oxygen should be treated with SARS-CoV-2-specific monoclonal antibodies (at present, casirivimab and imdevimab). Patients needing no more than low-flow oxygen should additionally be treated with janus kinase (JAK) inhibitors. All patients who need oxygen (low-flow, high-flow, noninvasive ventilation/CPAP, invasive ventilation) should be given systemic corticosteroids. Tocilizumab should be given to patients with a high oxygen requirement and progressively severe COVID-19 disease, but not in combination with JAK inhibitors.

CONCLUSION

Noninvasive ventilation, high-flow oxygen therapy, prone positioning, and invasive ventilation are important elements of the treatment of hypoxemic patients with COVID-19. A reduction of mortality has been demonstrated for the administration of monoclonal antibodies, JAK inhibitors, corticosteroids, tocilizumab, and therapeutic anticoagulation to specific groups of patients.

Для цитирования: Kluge Stefan, Malin Jakob J, Fichtner Falk, Müller Oliver J, Skoetz Nicole, Karagiannidis Christian, Guideline Development Group. Clinical Practice Guideline: Recommendations on the In-hospital Treatment of Patients with COVID-19.. Deutsches Arzteblatt international. 2021. DOI: 10.3238/arztebl.m2021.0374.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.